Table 2B.
Correlation of overexpression of CD62L with clinical outcome
| Dataset | Fold change |
Gene Rank |
Number of samples (Dead, Alive) |
P-value |
|---|---|---|---|---|
| Recurrence in superficial bladder cancers | ||||
| Stransky – 2006 | 2.22 | 141 | 25 (22, 3)* | 3.00 E-3 |
| Dead at 1 yr in superficial bladder cancers | ||||
| Blaveri -2005 | 1.67 | 291 | 19 (14, 5) | |
| Dead at 3 yr in superficial bladder cancers | ||||
| Blaveri -2005 | 1.89 | 94 | ||
(primary recurrence, recurrence)